Wednesday, 30 April 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 30 April 2025
News

Blockbuster year on the horizon

Posted 18 May 2023 AM

A handful of new agents with blockbuster potential recently approved by overseas jurisdictions hints at what's on the cards for Australia in 2023 - and into next year.

A recent Evaluate Vantage analysis shows the launch of six products - mostly in the US - is already underway, and there's no shortage of pending regulatory news for the remainder of the year, according to the analytics company.

To see the whole article, please login


Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.